Abstract
Presented at the Midyear Clinical Meeting.
This evaluation found that appropriate use of fidaxomicin improved after addition to formulary with use restrictions, along with a decrease in 30-day CDI recurrence.
Document Type
Poster
Publication Date
2025
Recommended Citation
Koeva, Anna PharmD, "Stool rules: evaluation of fidaxomicin use before and after formulary addition and implementation of use criteria" (2025). Pharmacy Residency. 57.
https://researchrepository.parkviewhealth.org/pharmresidency/57